On track for re-rating. We maintain BUY on DLF post positive pre-sales trajectory in Phase V projects, debt reduction and strong lease rental momentum. Our SOTP-based TP is maintained at Rs 258/sh. DLF balance sheet is strong post QIP and promoter fund infusion.
DLF has successfully completed a QIP of INR31.7bn involving an issuance of 173mn shares at INR183.4 apiece. This paves the way for the balance fund infusion of INR22.5bn by promoters (after injection of INR90bn in FY18) as well as conversion of debentures/warrants worth the entire INR112.5bn into equity shares. Leverage would, thus, fall off. Importantly, it also removes regulatory uncertainties regarding fund infusion. Besides, DLF’s operations are improving gradually; we believe, the pace of inventory liquidation will be a key trigger for the stock. Factoring in equity dilution and leverage reduction in our projections, wemaintain ‘BUY’ with a revised target price of INR237/share (versus INR216 earlier).